Uri Lopatin co-founded Assembly Pharma and served as Chief Medical Officer before its merger with Assembly Biosciences in 2014, where he held the role of CMO and VP of R&D and oversaw clinical development of hepatitis B antivirals. He previously worked as a physician-researcher at Schering Plough, Roche, and Gilead Sciences, and completed medical training at UMDNJ, NYU, and the NIH.
Intro paths
YC
Uri went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
→
In turn, Uri can intro founders to Pardes Biosciences's investors below.
Pardes Biosciences's investors · 3
Co-founders
UA
Uri A. LoptainExecutive Officer, Director
MA
Mark AueurbachDirector
MD
Michael D. VarneyDirector
JJ
J. Jay LobellDirector
HH
Heidi HensonExecutive Officer
EL
Elizabeth LacyExecutive Officer
LA
Lee ArnoldExecutive Officer
JB
James B. TananbaumDirector